A detailed history of Geode Capital Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,193,927 shares of HAE stock, worth $98.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,193,927
Previous 1,172,380 1.84%
Holding current value
$98.2 Million
Previous $97 Million 1.07%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.45 - $91.58 $1.56 Million - $1.97 Million
21,547 Added 1.84%
1,193,927 $96 Million
Q2 2024

Aug 09, 2024

BUY
$81.24 - $97.37 $3.82 Million - $4.57 Million
46,964 Added 4.17%
1,172,380 $97 Million
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $2.87 Million - $3.44 Million
40,340 Added 3.72%
1,125,416 $96.1 Million
Q4 2023

Feb 13, 2024

BUY
$80.59 - $92.61 $4.15 Million - $4.77 Million
51,474 Added 4.98%
1,085,076 $92.8 Million
Q3 2023

Nov 13, 2023

BUY
$82.56 - $93.49 $3.48 Million - $3.94 Million
42,184 Added 4.25%
1,033,602 $92.6 Million
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $3.86 Million - $4.27 Million
47,696 Added 5.05%
991,418 $84.4 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $2.44 Million - $3.04 Million
33,570 Added 3.69%
943,722 $78.1 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $1.82 Million - $2.12 Million
24,628 Added 2.78%
910,152 $71.6 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $1.31 Million - $1.63 Million
20,740 Added 2.4%
885,524 $65.6 Million
Q2 2022

Aug 12, 2022

SELL
$49.27 - $66.08 $826,602 - $1.11 Million
-16,777 Reduced 1.9%
864,784 $56.4 Million
Q1 2022

May 13, 2022

BUY
$43.77 - $63.22 $1.45 Million - $2.1 Million
33,205 Added 3.91%
881,561 $55.7 Million
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $862,021 - $1.3 Million
17,397 Added 2.09%
848,356 $45 Million
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $1.53 Million - $1.88 Million
-26,632 Reduced 3.11%
830,959 $58.7 Million
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $12.4 Million - $28.5 Million
240,178 Added 38.9%
857,591 $57.1 Million
Q1 2021

May 12, 2021

BUY
$111.01 - $139.48 $4.42 Million - $5.56 Million
39,860 Added 6.9%
617,413 $68.5 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $2.97 Million - $4.01 Million
33,413 Added 6.14%
577,553 $68.6 Million
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $4.86 Million - $6.01 Million
-64,238 Reduced 10.56%
544,140 $47.5 Million
Q2 2020

Aug 13, 2020

SELL
$84.96 - $118.91 $13.1 Million - $18.3 Million
-154,000 Reduced 20.2%
608,378 $54.5 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $1.05 Million - $1.72 Million
14,108 Added 1.89%
762,378 $76 Million
Q4 2019

Feb 13, 2020

BUY
$114.37 - $129.46 $2.23 Million - $2.53 Million
19,509 Added 2.68%
748,270 $86 Million
Q3 2019

Nov 12, 2019

BUY
$117.16 - $138.52 $3.08 Million - $3.64 Million
26,259 Added 3.74%
728,761 $91.9 Million
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $3.33 Million - $4.9 Million
40,680 Added 6.15%
702,502 $84.5 Million
Q1 2019

May 14, 2019

BUY
$83.25 - $102.12 $2.76 Million - $3.38 Million
33,127 Added 5.27%
661,822 $57.9 Million
Q4 2018

Feb 13, 2019

BUY
$90.66 - $116.63 $2.48 Million - $3.19 Million
27,344 Added 4.55%
628,695 $62.9 Million
Q3 2018

Nov 13, 2018

SELL
$89.96 - $114.58 $1.13 Million - $1.44 Million
-12,606 Reduced 2.05%
601,351 $68.9 Million
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $7.78 Million - $10.4 Million
108,718 Added 21.52%
613,957 $55.1 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $1.76 Million - $2.16 Million
29,036 Added 6.1%
505,239 $37 Million
Q4 2017

Feb 13, 2018

SELL
$44.96 - $58.99 $180,514 - $236,844
-4,015 Reduced 0.84%
476,203 $27.7 Million
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $1.01 Million - $1.13 Million
25,128 Added 5.52%
480,218 $21.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
455,090
455,090 $18 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.22B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.